UPDATE: Barclays Starts Tarsus Pharmaceuticals (TARS) at Overweight
Tweet Send to a Friend
(Updated - August 1, 2022 6:00 AM EDT)
Barclays analyst Balaji Prasad initiates coverage on Tarsus Pharmaceuticals (NASDAQ: TARS) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst Balaji Prasad initiates coverage on Tarsus Pharmaceuticals (NASDAQ: TARS) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
